ArticleMethodsX2026
An accessible and open-source workflow for fabrication of custom PDMS culture chambers using 3D printing.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Custom cell culture platforms are widely used in tissue engineering applications. However, their fabrication often requires specialized microfabrication equipment and advanced technical skills, limiting accessibility. This work presents an accessible and open-source workflow for the fabrication of custom PDMS culture chambers. This workflow focuses on the use of parametric CAD designs, 3D-printed molds, resin casting and plasma-free bonding. The proposed approach allows users to generate customized molds adapted to the experimental requirements using a graphical interface without extensive CAD knowledge. The molds can be manufactured using commonly available 3D printers or outsourced at relatively low cost. Device assembly is performed using uncured PDMS as a bonding agent, eliminating the need for plasma bonding equipment. The resulting culture chambers were validated through watertightness testing and biological evaluation using N2a cell cultures. Cell viability after 72 h of culture was comparable to that observed in standard culture plates. By reducing requirements for specialized equipment and technical expertise, this workflow facilitates the rapid, low-cost and reproducible fabrication of customized PDMS culture platforms for tissue engineering and related biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.